she did not receive her 2nd Moderna covid vaccine/agent told her not to receive the 2nd dose; very upset; Sharp pain; arm started aching again; burning,Burning sensation; tingling that moved around from arm to legs to face,Tingling/Prikling sensation  sharp pains radiatingall over body,arm back,hand,face,legs head; it became red and hot,arm hot; it became red,Local redness,arm red; arm was sore,achy hand; Local Itching; sneezing; Hypersensitive reaction; headache; chills; nausea; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (arm was sore,achy hand), VACCINATION SITE ERYTHEMA (it became red,Local redness,arm red), VACCINATION SITE WARMTH (it became red and hot,arm hot), SKIN BURNING SENSATION (burning,Burning sensation) and PAIN IN EXTREMITY (arm started aching again) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Environmental allergy, Hay fever, Drug allergy (Drug allergy- steroids feels like weak, dizzy, lost control, could not function, called 911), Drug allergy (Drug allergy- Novacaine feels like rapid heart rate, dizzy weak, headache.), Drug allergy (Drug allergy- codeine feels like weak, dizzy, headache, sensations over body.), Drug allergy (Drug allergy- diuretics feels like weak, dizzy, headache, sensations over body.), Motion sickness, Asthma, Blood pressure high, Nodule and Thyroid disorder. Concomitant products included VALSARTAN (DIOVAN) for Blood pressure, UBIDECARENONE (COQ 10), ASCORBIC ACID, COLECALCIFEROL (VITAMIN D 3) and CALCIUM for an unknown indication.    On 16-Jan-2021 at 10:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced VACCINATION SITE PAIN (arm was sore,achy hand) and SNEEZING (sneezing). 16-Jan-2021, the patient experienced PRURITUS (Local Itching), HYPERSENSITIVITY (Hypersensitive reaction), HEADACHE (headache), CHILLS (chills) and NAUSEA (nausea). On 18-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (it became red,Local redness,arm red). On 20-Jan-2021, the patient experienced VACCINATION SITE WARMTH (it became red and hot,arm hot). On 22-Jan-2021, the patient experienced PARAESTHESIA (tingling that moved around from arm to legs to face,Tingling/Prikling sensation  sharp pains radiatingall over body,arm back,hand,face,legs head). On 24-Jan-2021, the patient experienced SKIN BURNING SENSATION (burning,Burning sensation). On 26-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm started aching again). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (she did not receive her 2nd Moderna covid vaccine/agent told her not to receive the 2nd dose), FEELING ABNORMAL (very upset) and PAIN (Sharp pain). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of UNK dosage form (topical) at a dose of UNK dosage form. On 06-Mar-2021, VACCINATION SITE PAIN (arm was sore,achy hand), VACCINATION SITE ERYTHEMA (it became red,Local redness,arm red), VACCINATION SITE WARMTH (it became red and hot,arm hot), SKIN BURNING SENSATION (burning,Burning sensation), PAIN IN EXTREMITY (arm started aching again), PARAESTHESIA (tingling that moved around from arm to legs to face,Tingling/Prikling sensation  sharp pains radiatingall over body,arm back,hand,face,legs head), FEELING ABNORMAL (very upset), PRURITUS (Local Itching), SNEEZING (sneezing), HYPERSENSITIVITY (Hypersensitive reaction), PAIN (Sharp pain), HEADACHE (headache), CHILLS (chills) and NAUSEA (nausea) had resolved. At the time of the report, PRODUCT DOSE OMISSION ISSUE (she did not receive her 2nd Moderna covid vaccine/agent told her not to receive the 2nd dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, SARS-CoV-2 antibody test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: Initial additional document received: updated contact information, events and lab data updated. On 02-Aug-2021: Significant Follow up: Vaccine 1st dose time, patient information (heightt, weight, race), medical history, concomitant medications, events top date n outcome updated.